Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by AmorFatiforlifeon Feb 12, 2021 12:07am
143 Views
Post# 32549274

RE:RE:Maybe the company that gave them a 6.5M tip could help them?

RE:RE:Maybe the company that gave them a 6.5M tip could help them?IMHO, I have always felt that this was an acquisition play. The amount of time, $, and resources that Spectral would need to expend to build out a sales and marketing team would be quite laborious. Based on their current sales efforts I'm pretty sure the local kids on the corner put more effort into selling that EDT has. Therefore, one would assume that a company like Baxter, that already has the customer base, contacts, and manufacturing abilities would do a much more amicable job of pushing this out to the market. As MM alluded to, I believe the question is do they take the whole pie or just part??? I'm really hoping we get some guidance and some insight into Tigris results with our next company update. There are a lot of eyes out there on biotech companies right now.. slow and steady wins the race. Four years in the making for myself... I know some of the others have been here much longer... Night all Regards
<< Previous
Bullboard Posts
Next >>